Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (97)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kujala, P.
Right arrow Articles by Ruutiainen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kujala, P.
Right arrow Articles by Ruutiainen, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol 120, Issue 2 289-297, Copyright © 1997 by Oxford University Press


ARTICLES

The progress of cognitive decline in multiple sclerosis. A controlled 3- year follow-up

P Kujala, R Portin and J Ruutiainen
Masku Neurological Rehabilitation Centre, Masku, Finland.

The purpose of this study was to illustrate how cognitive functioning evolves over time in patients with multiple sclerosis. We followed the evolution of cognitive performances in two clinically and demographically similar multiple sclerosis groups, the 'cognitively preserved' (n = 20) and the 'cognitively mildly deteriorated' (n = 22), and in healthy controls (n = 34). We conducted the follow-up examination using the Mild Deterioration Battery, the Mini-Mental State Examination, and a set of additional neuropsychological measures after an interval of 3 years. The drop-out rate in our study was only 5%. The 'cognitively preserved' multiple sclerosis group showed substantial neuropsychological stability by performing as well as the controls both at baseline and at follow-up. By contrast, the initially 'cognitively mildly deteriorated' group demonstrated progressive cognitive decline on many neuropsychological tests. The intermediate-length screening battery, the Mild Deterioration Battery, was sensitive to this decline, whereas the briefer Mini-Mental State Examination was not. The progressive cognitive decline could not be predicted from other disease variables. The study demonstrated that intact cognitive functioning in multiple sclerosis may remain stable, whereas incipient cognitive decline seems to be widespread and progressive in nature. Thus, progressive cognitive deterioration should be considered as one of the characteristics of multiple sclerosis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
F Patti, M. Amato, M Trojano, S Bastianello, M. Tola, B Goretti, L Caniatti, E Di Monte, P Ferrazza, V Brescia Morra, et al.
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study
Multiple Sclerosis, July 1, 2009; 15(7): 779 - 788.
[Abstract] [PDF]


Home page
Mult SclerHome page
G Koutsis, M Panas, E Giogkaraki, G Karadima, C Sfagos, and D Vassilopoulos
An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis
Multiple Sclerosis, February 1, 2009; 15(2): 174 - 179.
[Abstract] [PDF]


Home page
Mult SclerHome page
F Patti
Cognitive impairment in multiple sclerosis
Multiple Sclerosis, January 1, 2009; 15(1): 2 - 8.
[Abstract] [PDF]


Home page
Mult SclerHome page
B Duque, J Sepulcre, B Bejarano, L Samaranch, P Pastor, and P Villoslada
Memory decline evolves independently of disease activity in MS
Multiple Sclerosis, August 1, 2008; 14(7): 947 - 953.
[Abstract] [PDF]


Home page
NeurologyHome page
J. Shi, C. B. Zhao, T. L. Vollmer, T. M. Tyry, and S. M. Kuniyoshi
APOE {varepsilon}4 allele is associated with cognitive impairment in patients with multiple sclerosis
Neurology, January 15, 2008; 70(3): 185 - 190.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. P. Amato, E. Portaccio, B. Goretti, V. Zipoli, M. Battaglini, M. L. Bartolozzi, M. L. Stromillo, L. Guidi, G. Siracusa, S. Sorbi, et al.
Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis
Arch Neurol, August 1, 2007; 64(8): 1157 - 1161.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J Sepulcre, S Vanotti, R Hernandez, G Sandoval, F Caceres, O Garcea, and P Villoslada
Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test
Multiple Sclerosis, April 1, 2006; 12(2): 187 - 195.
[Abstract] [PDF]


Home page
BrainHome page
S. J. Camp, V. L. Stevenson, A. J. Thompson, G. T. Ingle, D. H. Miller, C. Borras, B. Brochet, V. Dousset, M. Falautano, M. Filippi, et al.
A longitudinal study of cognition in primary progressive multiple sclerosis
Brain, December 1, 2005; 128(12): 2891 - 2898.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S. G Lynch, B. A Parmenter, and D. R Denney
The association between cognitive impairment and physical disability in multiple sclerosis
Multiple Sclerosis, August 1, 2005; 11(4): 469 - 476.
[Abstract] [PDF]


Home page
Mult SclerHome page
H Zephir, J de Seze, K Dujardin, G Dubois, M Cabaret, S Bouillaguet, D Ferriby, T Stojkovic, and P Vermersch
One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis
Multiple Sclerosis, June 1, 2005; 11(3): 360 - 363.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Achiron, M Polliack, S M Rao, Y Barak, M Lavie, N Appelboim, and Y Harel
Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves
J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 744 - 749.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M S A Deloire, E Salort, M Bonnet, Y Arimone, M Boudineau, H Amieva, B Barroso, J-C Ouallet, C Pachai, E Galliaud, et al.
Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, April 1, 2005; 76(4): 519 - 526.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. K. Salminen, R. I. Portin, A. Koskinen, H. Helenius, and M. Nurmi
Associations between Serum Testosterone Fall and Cognitive Function in Prostate Cancer Patients
Clin. Cancer Res., November 15, 2004; 10(22): 7575 - 7582.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. J. Archibald, X. Wei, J. N. Scott, C. J. Wallace, Y. Zhang, L. M. Metz, and J. R. Mitchell
Posterior fossa lesion volume and slowed information processing in multiple sclerosis
Brain, July 1, 2004; 127(7): 1526 - 1534.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Gadea, M. C. Martinez-Bisbal, L. Marti-Bonmati, R. Espert, B. Casanova, F. Coret, and B. Celda
Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis
Brain, January 1, 2004; 127(1): 89 - 98.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M R Piras, I Magnano, E D G Canu, K S Paulus, W M Satta, A Soddu, M Conti, A Achene, G Solinas, and I Aiello
Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings
J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 878 - 885.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. P. Amato, G. Ponziani, G. Siracusa, and S. Sorbi
Cognitive Dysfunction in Early-Onset Multiple Sclerosis: A Reappraisal After 10 Years
Arch Neurol, October 1, 2001; 58(10): 1602 - 1606.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
D. Karussis, H. L Weiner, and O. Abramsky
Multiple sclerosis vs Lyme disease: A case presentation to a discussant and a review of the literature
Multiple Sclerosis, December 1, 1999; 5(6): 395 - 402.
[PDF]


Home page
Mult SclerHome page
W. W Beatty
Assessment of cognitive and psychological functions in patients with multiple sclerosis: considerations for databasing
Multiple Sclerosis, August 1, 1999; 5(4): 239 - 243.
[Abstract] [PDF]


Home page
Mult SclerHome page
G Comi, V Martinelli, T Locatelli, L Leocani, and S Medaglini
Neurophysiological and cognitive markers of disease evolution in multiple sclerosis
Multiple Sclerosis, June 1, 1998; 4(3): 260 - 265.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.